Xeris Biopharma Holdings Inc (XERS)
3.475
+0.06
(+1.61%)
USD |
NASDAQ |
Dec 24, 13:00
3.40
-0.08
(-2.16%)
After-Hours: 13:59
Xeris Biopharma Holdings Shareholders Equity (Quarterly): -28.32M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 69.77M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.10M |
| Total Liabilities (Quarterly) | 349.43M |
| Debt to Equity Ratio | -8.166 |
| Current Ratio | 1.789 |
| Net Debt Paydown Yield | -2.03% |